Press Releases on February 28, 2023 - EIN Presswire - Press Release Distribution Service

Published on February 28, 2023 - 21:05 GMT

Myriad Genetics Reports Fourth Quarter Financial Results; Fourth Quarter Revenue of $177.8 Million Grew 11% Year-Over-Year Driven ...

Highlights: Fourth quarter testing volumes grew 26% year-over-year, and 11% year-over-year excluding the contribution from the recent acquisition of Gateway Genomics and its SneakPeek® Early Gender DNA Test. GeneSight, the company's pharmacogenomics …

Distribution channels: Business & Economy, Technology ...

Published on February 28, 2023 - 21:05 GMT

Jamf Announces Fourth Quarter and Fiscal Year 2022 Financial Results

Q4 total revenue year-over-year growth of 26% to $130.3 million; fiscal year total revenue growth of 31% to $478.8 million ARR year-over-year growth of 24% to $512.5 million as of December 31, 2022 Cash flow provided by operations of $90.0 million for the …

Distribution channels: Business & Economy, Technology ...

Published on February 28, 2023 - 21:05 GMT

URBN Reports Q4 Results

PHILADELPHIA, Feb. 28, 2023 (GLOBE NEWSWIRE) -- Urban Outfitters, Inc. (NASDAQ:URBN), a leading lifestyle products and services company which operates a portfolio of global consumer brands comprised of the Anthropologie, BHLDN, Free People, FP Movement, …

Distribution channels: Business & Economy, Textiles & Fabric Industry ...

Published on February 28, 2023 - 21:05 GMT

Corcept Therapeutics Announces Fourth Quarter and Full-Year 2022 Audited Financial Results and Provides Corporate Update

MENLO PARK, Calif., Feb. 28, 2023 (GLOBE NEWSWIRE) -- Corcept Therapeutics Incorporated (NASDAQ: CORT), a commercial-stage company engaged in the discovery and development of medications to treat severe endocrine, oncologic, metabolic and neurological …

Distribution channels: Business & Economy, Healthcare & Pharmaceuticals Industry ...

Published on February 28, 2023 - 21:05 GMT

OrthoPediatrics Corp. Reports Fourth Quarter and Full Year 2022 Financial Results

Fourth Quarter 2022 Revenue Increased 25% Year-over-Year Full Year 2022 Revenue Increased 25% Year-over-Year WARSAW, Ind., Feb. 28, 2023 (GLOBE NEWSWIRE) -- OrthoPediatrics Corp. (“OrthoPediatrics” or the “Company”) (Nasdaq: KIDS), a company focused …

Distribution channels: Business & Economy, Healthcare & Pharmaceuticals Industry ...

Published on February 28, 2023 - 21:05 GMT

Silk Road Medical Reports Fourth Quarter and Full Year 2022 Financial Results and Provides 2023 Financial Outlook

SUNNYVALE, Calif., Feb. 28, 2023 (GLOBE NEWSWIRE) -- Silk Road Medical, Inc. (Nasdaq: SILK), a company focused on reducing the risk of stroke and its devastating impact, today reported financial results for the three months and full year ended December 31 …

Distribution channels: Business & Economy, Healthcare & Pharmaceuticals Industry ...

Published on February 28, 2023 - 21:05 GMT

Chimerix to Present at Cowen and Company 43rd Annual Health Care Conference

DURHAM, N.C., Feb. 28, 2023 (GLOBE NEWSWIRE) -- Chimerix (NASDAQ:CMRX), a biopharmaceutical company whose mission is to develop medicines that meaningfully improve and extend the lives of patients facing deadly diseases, today announced that Mike Sherman, …

Distribution channels: Culture, Society & Lifestyle, Healthcare & Pharmaceuticals Industry ...

Published on February 28, 2023 - 21:05 GMT

Aligos Therapeutics to Announce Fourth Quarter Results March 9, 2023

SOUTH SAN FRANCISCO, Calif., Feb. 28, 2023 (GLOBE NEWSWIRE) -- Aligos Therapeutics, Inc. (Nasdaq: ALGS, “Aligos”, the “Company”), a clinical stage biopharmaceutical company focused on developing novel therapeutics to address unmet medical needs in …

Distribution channels: Culture, Society & Lifestyle, Healthcare & Pharmaceuticals Industry ...

Published on February 28, 2023 - 21:05 GMT

Aravive Announces FDA Orphan Drug Designation Granted to Batiraxcept for the Treatment of Pancreatic Cancer

Dose escalation portion of ongoing Phase 1b/2 pancreatic adenocarcinoma trial initiated, with preliminary results expected in 2H 2023 HOUSTON, Feb. 28, 2023 (GLOBE NEWSWIRE) -- Aravive, Inc. (Nasdaq: ARAV, “the Company”), a late clinical-stage oncology …

Distribution channels: Healthcare & Pharmaceuticals Industry ...

Published on February 28, 2023 - 21:05 GMT

Proterra CEO Gareth Joyce Appointed by President Biden to the President’s Export Council

BURLINGAME, Calif., Feb. 28, 2023 (GLOBE NEWSWIRE) -- Proterra Inc (NASDAQ: PTRA), a leading innovator in commercial vehicle electrification technology, today announced that Chief Executive Officer Gareth Joyce has been appointed by President Biden to …

Distribution channels:

Published on February 28, 2023 - 21:05 GMT

Flywire Reports Fourth Quarter and Fiscal-Year 2022 Financial Results

Fourth Quarter Revenue Increased 42% Year-over-Year Fourth Quarter Revenue Less Ancillary Services Increased 47% Year-over-Year Fourth Quarter Revenue Less Ancillary Services at Constant Currency Increased 57% Year-Over-Year Fourth Quarter Gross Profit …

Distribution channels: Banking, Finance & Investment Industry, Business & Economy ...

Published on February 28, 2023 - 21:04 GMT

Shield Law Clears House

OLYMPIA — Today, the Washington House of Representatives passed a landmark Shield Law to protect those who seek reproductive & gender-affirming care in the state. House Bill 1469, introduced by State Rep. Drew Hansen (D-Bainbridge Island), responds to …

Distribution channels:

Published on February 28, 2023 - 21:04 GMT

COURTS MOURN THE PASSING OF JUDGE REGNAL W. GARFF

Posted: February 28, 2023 Utah Courts Salt Lake City, UT – The Utah State Courts mourn the passing of Judge Regnal Washington Garff, Jr. and thank him for his exemplary service to the people of Utah for many years. Judge Garff passed away on February 25, …

Distribution channels:

Published on February 28, 2023 - 21:03 GMT

Governor Abbott Announces Music Friendly Texas Community Workshop In College Station

February 28, 2023 | Austin, Texas | Press Release Governor Greg Abbott today announced the Texas Music Office (TMO), the City of College Station, and Visit College Station will co-host a Music Friendly Texas Community workshop on Tuesday, March 7. “Music …

Distribution channels:

Published on February 28, 2023 - 21:03 GMT

PROCEPT BioRobotics Reports Fourth Quarter and Full Year 2022 Results

REDWOOD CITY, Calif., Feb. 28, 2023 (GLOBE NEWSWIRE) -- PROCEPT® BioRobotics Corporation (Nasdaq: PRCT) (the “Company”), a surgical robotics company focused on advancing patient care by developing transformative solutions in urology, today reported …

Distribution channels: Business & Economy, Healthcare & Pharmaceuticals Industry ...

Published on February 28, 2023 - 21:03 GMT

Health Catalyst Reports Fourth Quarter and Year End 2022 Results

SOUTH JORDAN, Utah, Feb. 28, 2023 (GLOBE NEWSWIRE) -- Health Catalyst, Inc. ("Health Catalyst," Nasdaq: HCAT), a leading provider of data and analytics technology and services to healthcare organizations, today reported financial results for the …

Distribution channels: Business & Economy, Healthcare & Pharmaceuticals Industry ...

Published on February 28, 2023 - 21:03 GMT

Franchise Group, Inc. Announces Approval of Quarterly Preferred Dividend

DELAWARE, Ohio, Feb. 28, 2023 (GLOBE NEWSWIRE) -- Franchise Group, Inc. (NASDAQ: FRG) (“Franchise Group” or the “Company”) today announced that its Board of Directors approved a quarterly dividend of $0.46875 per share to Series A Cumulative Perpetual …

Distribution channels: Banking, Finance & Investment Industry ...

Published on February 28, 2023 - 21:02 GMT

iSpecimen to Report Fourth Quarter and Full Year 2022 Results on March 14, 2023

LEXINGTON, Mass., Feb. 28, 2023 (GLOBE NEWSWIRE) -- iSpecimen Inc. (Nasdaq: ISPC) (“iSpecimen” or the “Company”), an online global marketplace that connects scientists in need of biospecimens for medical research with a network of healthcare specimen …

Distribution channels: Culture, Society & Lifestyle, Technology ...

Published on February 28, 2023 - 21:02 GMT

SLR Investment Corp. Announces Quarter and Fiscal Year Ended December 31, 2022 Financial Results

Net Investment Income of $0.41 Per Share for Q4 2022 Distributions of $0.41 Per Share for Q1 2023 NEW YORK , Feb. 28, 2023 (GLOBE NEWSWIRE) -- SLR Investment Corp. (NASDAQ: SLRC) (the “Company” or “SLRC”) today reported net investment income of $22.5 …

Distribution channels: Banking, Finance & Investment Industry, Business & Economy ...

Published on February 28, 2023 - 21:02 GMT

Allogene Therapeutics Reports Fourth Quarter and Full Year 2022 Financial Results and Provides Business Update

Initiated Industry’s First Potentially Pivotal Phase 2 Allogeneic CAR T Trial, ALPHA2, in Relapsed/Refractory (R/R) Large B Cell Lymphoma (LBCL) Presented Data Highlighting Industry-Leading Allogeneic CAR T Portfolio CD19 (ALLO-501/A): Six Month Durability …

Distribution channels: Business & Economy, Healthcare & Pharmaceuticals Industry ...